SUDARSHAN PHARMA INDUSTRIES LTD : TERMINATES ACQUISITION PROPOSAL

• Proposal to acquire 9.50% equity shares of common stock of Med Therapy Biotechnology Inc., USA ("Med Therapy") has been terminated. • Proposal to acquire 1.50% each of the equity shares of common stock of Med Therapy by Mr. Hemal Mehta and Mr. Sachin Mehta also stands terminated. • Updates on acquisition of M/s. Med Therapy Biotechnology Inc., USA - Company Letter bearing ref. no. SPIL/CS/SE/2026-2027/57 dated 5th September, 2026 and SPIL/CS/SE/2026-2027/58 dated 15th September, 2026

Sudarshan Pharma Industries Ltd

Open attachment

← Back to feed